Characterizing Safety and Clinical Outcomes Associated with High-Dose Micafungin Utilization in Patients with Proven Invasive Candidiasis.

Grant, Victoria C; Nguyen, Kenneth; Rodriguez, Sasha; Zhou, Anna Y; Abdul-Mutakabbir, Jacinda C; Tan, Karen K

Grant, Victoria C; Nguyen, Kenneth; Rodriguez, Sasha; Zhou, Anna Y; Abdul-Mutakabbir, Jacinda C; Tan, Karen K.

Afiliación

Grant VC; Department of Pharmacy Practice, Loma Linda University Medical Center, Loma Linda, CA 92354, USA.
Nguyen K; Department of Pharmacy Practice, Loma Linda University School of Pharmacy, Loma Linda, CA 92354, USA.
Rodriguez S; Department of Pharmacy Practice, Loma Linda University School of Pharmacy, Loma Linda, CA 92354, USA.
Zhou AY; Department of Pharmacy Practice, Loma Linda University School of Pharmacy, Loma Linda, CA 92354, USA.
Abdul-Mutakabbir JC; Department of Pharmacy Practice, Loma Linda University Medical Center, Loma Linda, CA 92354, USA.
Tan KK; Department of Pharmacy Practice, Loma Linda University School of Pharmacy, Loma Linda, CA 92354, USA.

Trop Med Infect Dis ; 7(2)2022 Feb 03.

Article en En | MEDLINE | ID: mdl-35202218

Palabras clave

critically ill; invasive candidiasis; micafungin; obesity

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Trop Med Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google